{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:25:41Z","timestamp":1784741141129,"version":"3.55.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T00:00:00Z","timestamp":1522627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organization for Health Research and Development","doi-asserted-by":"crossref","award":["171002304"],"award-info":[{"award-number":["171002304"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0195260","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T17:33:38Z","timestamp":1522690418000},"page":"e0195260","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9079-9519","authenticated-orcid":true,"given":"Anneleen","family":"Berende","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette","family":"Nieuwenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadewych J. M.","family":"ter Hofstede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidel J.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel L.","family":"Vogelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Tromp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri\u00ebt","family":"van Middendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Rogier T.","family":"Donders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea W. M.","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart Jan","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy M. M.","family":"Adang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"issue":"10","key":"ref1","first-page":"1","article-title":"Centers for Disease C, Prevention. Surveillance for Lyme disease\u2014United States, 1992\u20132006","volume":"57","author":"RM Bacon","year":"2008","journal-title":"MMWR Surveill Summ"},{"issue":"27","key":"ref2","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.27.19906-en","article-title":"Lyme borreliosis in Europe","volume":"16","author":"A Rizzoli","year":"2011","journal-title":"Euro Surveill"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/649920","article-title":"Antibiotic treatment duration and long-term outcomes of patients with early lyme disease from a lyme disease-hyperendemic area","volume":"50","author":"TJ Kowalski","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"GP Wormser","year":"2003","journal-title":"Ann Intern Med"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","article-title":"Lyme borreliosis: clinical case definitions for diagnosis and management in Europe","volume":"17","author":"G Stanek","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/eurpub\/ckv091","article-title":"The burden of Lyme borreliosis expressed in disability-adjusted life years","volume":"25","author":"CC van den Wijngaard","year":"2015","journal-title":"Eur J Public Health"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"e0116767","DOI":"10.1371\/journal.pone.0116767","article-title":"Health care costs, utilization and patterns of care following Lyme disease","volume":"10","author":"ER Adrion","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ttbdis.2014.09.004","article-title":"Epidemiology and cost of hospital care for Lyme borreliosis in Germany: lessons from a health care utilization database analysis","volume":"6","author":"B Lohr","year":"2015","journal-title":"Ticks Tick Borne Dis"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.cct.2012.08.009","article-title":"Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials","volume":"33","author":"AK Delong","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/1874205X01206010079","article-title":"A reappraisal of the u.s. Clinical trials of post-treatment lyme disease syndrome","volume":"6","author":"BA Fallon","year":"2012","journal-title":"Open Neurol J"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.amjmed.2013.02.014","article-title":"Treatment trials for post-Lyme disease symptoms revisited","volume":"126","author":"MS Klempner","year":"2013","journal-title":"Am J Med"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1586\/14787210.2014.940900","article-title":"Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease","volume":"12","author":"DJ Cameron","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"A Mygland","year":"2010","journal-title":"Eur J Neurol"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"GP Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"13","key":"ref15","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa1505425","article-title":"Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease","volume":"374","author":"A Berende","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/s12879-014-0543-y","article-title":"Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)\u2014design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis","volume":"14","author":"A Berende","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hec.1124","article-title":"The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies","volume":"15","author":"LM Lamers","year":"2006","journal-title":"Health Econ"},{"issue":"7143","key":"ref18","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bmj.316.7143.1529","article-title":"Perspectives in economic evaluation","volume":"316","author":"S Byford","year":"1998","journal-title":"BMJ"},{"key":"ref19","author":"M Drummond","year":"2015"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"P Dolan","year":"1997","journal-title":"Med Care"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1472-6963-13-217","article-title":"Feasibility, reliability and validity of a questionnaire on healthcare consumption and productivity loss in patients with a psychiatric disorder (TiC-P)","volume":"13","author":"C Bouwmans","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"ref22","author":"L Hakkaart\u2014van Roijen","year":"2015"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S0266462300009764","article-title":"Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire","volume":"12","author":"L van Roijen","year":"1996","journal-title":"Int J Technol Assess Health Care"},{"key":"ref24","unstructured":"Zinnige en duurzame zorg. Zoetermeer: Raad voor de Volksgezondheid en Zorg; 2006."},{"key":"ref25","author":"JJ Busschbach","year":"2010"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-14-13","article-title":"A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance","volume":"14","author":"BG Bell","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref27","article-title":"Antimicrobial resistance: global report on surveillance","year":"2014"},{"key":"ref28","article-title":"The State of the World\u2019s Antibiotics","author":"H Gelband","year":"2015"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0195260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T20:45:56Z","timestamp":1660769156000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0195260"}},"subtitle":[],"editor":[{"given":"Jacobus P.","family":"van Wouwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,2]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0195260","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,2]]}}}